enocitabine has been researched along with Cystadenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, S; Hirooka, C; Ichijo, M; Kiyozuka, Y; Noda, T; Oku, M; Yamamoto, T | 1 |
| Adachi, S; Akada, S; Ichijo, M; Kiyozuka, Y; Maruyama, M; Noda, T; Okamura, Y; Oku, M | 1 |
2 other study(ies) available for enocitabine and Cystadenocarcinoma
| Article | Year |
|---|---|
[Intraperitoneal (i.p.) chemotherapy in the management of ovarian cancer--pharmacokinetics and methods of sequential i.p. chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosyluracil; Carcinoma, Squamous Cell; Child; Cisplatin; Cystadenocarcinoma; Cytarabine; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Infusion Pumps; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Teratoma | 1990 |
[Pharmacokinetics of N4-behenoyl-1-beta-D-arabinofuranosylcytosine after intraperitoneal administration].
Topics: Aged; Antineoplastic Agents; Ascitic Fluid; Cystadenocarcinoma; Cytarabine; Female; Humans; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Peritonitis; Uterine Neoplasms | 1988 |